Previous studies have shown that histone deacetylases (HDACs) are important for gene expression because HDAC levels vary in different cancer types, and promising results with HDAC inhibitors (HDACis) combined with chemotherapeutic drugs in cancer treatment have been reported [4, 5]. The gene discussed is HDAC9; the disease is cancer.